Page last updated: 2024-11-01

omeprazole and Autoimmune Diseases

omeprazole has been researched along with Autoimmune Diseases in 8 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research Excerpts

ExcerptRelevanceReference
"Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors."1.31Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prasad, R1
De Silva, M1
Nomura, S1
Inami, N1
Kanazawa, S1
Hershko, C1
Hoffbrand, AV1
Keret, D1
Souroujon, M1
Maschler, I1
Monselise, Y1
Lahad, A1
Sivakumar, K1
Dalakas, MC1
Montseny, JJ1
Meyrier, A1
Stolte, M1
Meier, E1
Meining, A1
Grimaz, S1
Damiani, D1
Brosolo, P1
Skert, C1
Geromin, A1
de Pretis, G1
García Pérez, A1
Valverde de La Osa, J1
Giménez Samper, M1
Alonso García, I1

Reviews

1 review available for omeprazole and Autoimmune Diseases

ArticleYear
Immunoallergic granulomatous interstitial nephritis following treatment with omeprazole.
    American journal of nephrology, 1998, Volume: 18, Issue:3

    Topics: Aged; Anti-Ulcer Agents; Autoimmune Diseases; Humans; Kidney; Male; Myasthenia Gravis; Nephritis, In

1998

Other Studies

7 other studies available for omeprazole and Autoimmune Diseases

ArticleYear
Osteoporosis with underlying connective tissue disease: an unusual case.
    Annals of the New York Academy of Sciences, 2002, Volume: 966

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant

2002
The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura.
    European journal of haematology, 2004, Volume: 72, Issue:4

    Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Chemokines; Clarithromycin; Drug Therapy, Combi

2004
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
    Haematologica, 2005, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies

2005
Autoimmune syndrome induced by omeprazole.
    Lancet (London, England), 1994, Aug-27, Volume: 344, Issue:8922

    Topics: Autoimmune Diseases; Humans; Male; Middle Aged; Omeprazole

1994
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases;

1998
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helic

1999
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Fema

1999